{
  "folder": "IC-074",
  "content": "{{knowledge objective\n|Identifiant=OIC-074-05-B\n|Item_parent=Prescription and monitoring of psychotropic drugs (see item 330)\n|Item_parent_short=Prescription and monitoring of psychotropic drugs (see item 330)\n|Rank=B\n|Title=Antipsychotics: knowing the rules for correct use at all stages of life, particularly in elderly patients and/or those suffering from dementia.\n|Description=None\n|Rubric=Management\n|Contributors=\n|Order=5}}\nThe ''pre-therapeutic assessment'' prior to antipsychotic treatment includes a search for contraindications (ECG), any pregnancy, associated treatments and screening for metabolic disorders.\n\n'''Rules for the proper use''' of antipsychotics :\n\n* First-line molecules: second-generation antipsychotics;\n* Choice of drug based on response to previous treatments, contraindications and patient preferences;\n* Favour the drug with the fewest side effects;\n* Do not combine two QT-prolonging drugs;\n* Look for monotherapy and the minimum effective dose;\n* In emergencies, reserve the intramuscular route for states of intense agitation and avoid dose escalation or repetition;\n* Monitor clinical efficacy and adverse effects.",
  "question": {
    "question": "What is the preferred approach when combining antipsychotics for a patient?",
    "option_a": "Combine two first-generation antipsychotics for enhanced efficacy",
    "option_b": "Combine two second-generation antipsychotics, but only if the patient has a history of non-response to first-generation antipsychotics",
    "option_c": "Combine two drugs that prolong the QT interval, but only in patients with a history of cardiovascular disease",
    "option_d": "Favour the combination of two drugs with the fewest side effects, even if they prolong the QT interval",
    "correct_option": "A"
  }
}